Morbidity and Mortality Weekly Report: MMWRU.S. Department of Health, Education, and Welfare, Public Health Service, Center for Disease Control, 1996 |
Inni boken
Resultat 1-5 av 90
Side 447
... week totals ending May 4 , 1996 , with historical data United States , was incorrect . The graph below is correct ... WEEKS 1,316 580 249 37 54 15 221 40 195 372 0.03125 0.0625 0.125 0.25 0.5 1 2 4 Ratio ( Log Scale ) * Beyond Historical ...
... week totals ending May 4 , 1996 , with historical data United States , was incorrect . The graph below is correct ... WEEKS 1,316 580 249 37 54 15 221 40 195 372 0.03125 0.0625 0.125 0.25 0.5 1 2 4 Ratio ( Log Scale ) * Beyond Historical ...
Side 448
... week totals ending May 11 , 1996 , with historical data United States , was incorrect . The graph below is correct ... WEEKS 1,486 593 271 31 54 520 215 50 213 373 6 Beyond Historical Limits * The large apparent decrease in the number of ...
... week totals ending May 11 , 1996 , with historical data United States , was incorrect . The graph below is correct ... WEEKS 1,486 593 271 31 54 520 215 50 213 373 6 Beyond Historical Limits * The large apparent decrease in the number of ...
Side 449
... ending May 25 , 1996 , with historical data United States DISEASE DECREASE ... WEEKS 1,482 573 276 40 76 50 194 46 272 331 10 0.125 0.25 0.5 1 2 4 Ratio ... ending May 25 , 1996 ( 21st Week ) Anthrax Brucellosis Cholera Congenital rubella ...
... ending May 25 , 1996 , with historical data United States DISEASE DECREASE ... WEEKS 1,482 573 276 40 76 50 194 46 272 331 10 0.125 0.25 0.5 1 2 4 Ratio ... ending May 25 , 1996 ( 21st Week ) Anthrax Brucellosis Cholera Congenital rubella ...
Side 450
MMWR. TABLE II . Cases of selected notifiable diseases , United States , weeks ending May 25 , 1996 , and May 27 , 1995 ( 21st Week ) Escherichia coli O157 : H7 Hepatitis AIDS * Chlamydia NETSS ' PHLIS Gonorrhea C / NA , NB Legionellosis ...
MMWR. TABLE II . Cases of selected notifiable diseases , United States , weeks ending May 25 , 1996 , and May 27 , 1995 ( 21st Week ) Escherichia coli O157 : H7 Hepatitis AIDS * Chlamydia NETSS ' PHLIS Gonorrhea C / NA , NB Legionellosis ...
Side 451
... weeks ending May 25 , 1996 , and May 27 , 1995 ( 21st Week ) Lyme Disease Malaria Meningococcal Disease Syphilis ( Primary & Secondary ) Tuberculosis Rabies , Animal Cum . Cum . Cum . Cum . Cum . Cum . Cum . Cum . Cum . Cum . Cum . Cum ...
... weeks ending May 25 , 1996 , and May 27 , 1995 ( 21st Week ) Lyme Disease Malaria Meningococcal Disease Syphilis ( Primary & Secondary ) Tuberculosis Rabies , Animal Cum . Cum . Cum . Cum . Cum . Cum . Cum . Cum . Cum . Cum . Cum . Cum ...
Vanlige uttrykk og setninger
4-week totals Alaska Ariz associated ATLANTIC blastomycosis Calif CDC's Center for Infectious Centers for Disease clinical Colo Congenital rubella syndrome Conn contaminated Control and Prevention Cryptosporidiosis death Department of Health Dept diphtheria Disease Control doses Drug Editorial Note endophthalmitis ephedrine Epidemiology Escherichia coli exposure Guam Hawaii Hepatitis HIV infection hobo spider hospital Idaho identified Immunization increased infants Infectious Diseases injuries July Kans Laboratory Legionellosis lowa Lyme Disease Maine N.H. Malaria Mass measles Minn MMWR Series MMWR weekly N.Y. City National Center Nebr number of reported Ohio Okla onset Oreg outbreak PACIFIC patients Pertussis polio Poliomyelitis poliovirus Program Public Health Service Rabies Reporting Area 1996 risk Rubella Samoa C.N.M.I. scopolamine selected notifiable diseases smallpox surveillance TABLE Tenn testing tetanus United Updated Upstate N.Y. Utah vaccine W.S. CENTRAL Wash weeks ending June women
Populære avsnitt
Side 672 - Alabama, Arkansas, Delaware, District of Columbia, Florida, Georgia, Kentucky, Louisiana, Maryland, Mississippi, North Carolina, Oklahoma, South Carolina, Tennessee, Texas, Virginia, and West Virginia. West: Alaska, Arizona, California, Colorado, Hawaii, Idaho, Montana, Nevada, New Mexico, Oregon, Utah, Washington, and Wyoming.
Side 471 - O'Sullivan MJ, VanDyke R, Bey M, Shearer W, Jacobson RL, Jimenez E, O'Neill E, Bazin B, Delfraissy JF, Culnane M, Coombs R, Elkins M, Moye J, Stratton P, Balsley J. 1994. Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment.
Side 608 - Florida, Georgia, Illinois, Indiana, Iowa, Kentucky, Maine, Maryland, Massachusetts, Michigan, Minnesota, New Hampshire, New Jersey, New York, North Carolina, Ohio, Pennsylvania, Rhode Island, South Carolina, Tennessee, Vermont, Virginia, West Virginia, and Wisconsin— OME, Room, 2B, Post Office Building, Knoxville 2, Tennessee.
Side 610 - Blood lead levels in the US population. Phase 1 of the Third National Health and Nutrition Examination Survey (NHANES III, 1988 to 1991).
Side 530 - No health department, State or local, can effectively prevent or control disease without knowledge of when, where, and under what conditions cases are occurring.
Side 568 - Income in 1989.") Poverty statistics presented in census publications were based on a definition originated by the Social Security Administration in 1964 and subsequently modified by Federal interagency committees in 1969 and 1980 and prescribed by the Office of Management and Budget in Directive 14 as the standard to be used by Federal agencies for statistical purposes. At the core of this definition was the...
Side 464 - ... which involve one or more of the following: loss of consciousness, restriction of work or motion, transfer to another job, or medical treatment (other than first aid).
Side 670 - Recommendations of the US Public Health Service Task Force on the use of zidovudine to reduce perinatal transmission of human immunodeficiency virus.
Side 471 - Case-control study of HIV seroconversion in health-care workers after percutaneous exposure to HIV-infected blood — France, United Kingdom, and United States, January 1988-August 1994.
Side 512 - The budget also funds full participation in the Special Supplemental Nutrition Program for Women, Infants, and Children (WIC), which will provide benefits to 7.5 million people by the end of 1999.